Great post HT.
Wow, platform drug, pipeline in a drug, what a position we find ourselves in.
2 successful phase 2 trials, hopefully a 3rd to come, bolt on a couple more indications here via mouse models.
Hashan De silva had 2591 peak sales in 4 indications at conservative US$22bn
Lets say they drop PW and add another 5 indications conservatively as a TO package.
We potentially have a pipeline drug asset with initial peak sales potential for US $44-$50bn
I think its fair to say we all have underestimated the potential here.
What would BP pay this pipeline?
Pipeline-in-a-drug, page-8
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.72 |
Change
-0.030(0.22%) |
Mkt cap ! $1.753B | |||
| Open | High | Low | Value | Volume |
| $13.85 | $14.08 | $13.46 | $4.259M | 311.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 433 | $13.71 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.72 | 184 | 8 |
View Market Depth
| Last trade - 14.32pm 10/09/2024 (20 minute delay) ? |
| NEU (ASX) Chart |